Simon M. Poucher

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A_2aselective adenosine receptor antagonist

Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 364 citations · Full text

Medicine, Pharmacology, General Pharmacology +8

125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

T M Palmer, Simon M. Poucher, Kenneth A. Jacobson et al. · Molecular Pharmacology · 1995 · 90 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats

Victor P. Bilan, Eman Salah, Sheldon Bastacky et al. · Journal of Endocrinology · 2011 · 88 citations · Full text

Medicine, Nephrology, Pharmacology +17

The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats

Franka. MacDonald, Joanne E. Peel, H. B. Jones et al. · Diabetes Obesity and Metabolism · 2010 · 83 citations

Medicine, Endocrinology, Pharmacology +17

Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.

James A. Timmons, Simon M. Poucher, Dumitru Constantin‐Teodosiu et al. · Journal of Clinical Investigation · 1996 · 78 citations · Full text

Life Sciences, Biochemistry, Physiology +13